SRC and B-cell chronic lymphocytic leukemia: Consistent with previous observations in healthy donor platelets (29, 31), CLL platelet aggregation and PF4 secretion to S. aureus Newman and E. coli RS218 were inhibited by IV.3 mAb and by the Src inhibitor, dasatinib (Figures 1D, E).